{"id":621,"date":"2016-11-15T15:31:08","date_gmt":"2016-11-15T21:31:08","guid":{"rendered":"http:\/\/melissakaysimonds.com\/?p=621"},"modified":"2017-07-03T09:19:59","modified_gmt":"2017-07-03T14:19:59","slug":"stock-in-trade","status":"publish","type":"post","link":"https:\/\/melissakaysimonds.com\/?p=621","title":{"rendered":"Stock-In-Trade"},"content":{"rendered":"<p><em><strong>Stock-in-trade:<\/strong> something that someone or something does or makes very well and often.<\/em><\/p>\n<p>So I bought this stock a few years ago. It seemed like a sure thing.<\/p>\n<p>The company was developing a technology that might revolutionize early treatment of an incurable disease that is a global epidemic. That&#8217;s about as much detail as I care to give, except to say that throughout the R&amp;D of this\u00a0device, no aspersions have been cast its way and no ugly surprises have reared their heads during testing. Nevertheless, enrolling patients for the FDA approval study was a challenge. The study&#8217;s timeline stretched as the company struggled to bring test sites online, educate physicians, and attract suitable patients. Even the FDA&#8217;s approval for a fast-tracked study was not enough to get them past the unexpected cash drain. And therein lay the rub. Patient enrollment had to be abandoned as the company ran out of steam, a.k.a. moolah. This might have been an opportune time for another company to swoop in and snatch the promising technology, but a &#8220;poison pill&#8221; provision excluded unwanted takeovers. The equity price per share nosed over dramatically as investors lost confidence, not in the device, but in the team&#8217;s husbandry of it. All attempts to arrest the ensuing descent have been futile. The board\u00a0came up with a change in leadership, which drove the stock price even lower. The new leadership came up with\u00a0a change in strategy, then <em>another<\/em> change in strategy. All the while, the equity price tumbled\u00a0like a corpse on its way down a cliff. The short version of this very long and depressing tale is that the price per share this morning is roughly one percent of what the stockholders and even a handful of\u00a0analysts expected by now.<\/p>\n<p>All the hubbub began about four years ago following unprecedented results from an early feasibility study in which a large percentage of patients experienced marked improvement and a small percentage experienced complete reversal of the disease. One enthusiastic analyist, whose articles reflected a firm grasp of the disease and the technology&#8217;s effect on it, predicted rising share prices on a timeline that seemed reasonable but turned out to be a primrose path. Looking back over the many articles published during that time, it&#8217;s easy to find warnings about such unfettered enthusiasm. One in particular warned investors that the company did not have enough cash, cautioning them to wait for cheaper prices.<\/p>\n<p>The company is hanging on by their fingernails. They have acquired an approved device they hope will bring in enough revenue to keep them solvent in the short term and fund R&amp;D on their primary technology in the long term. I must admit, they are a scrappy and apparently nimble team, certainly too nimble for many stockholders&#8217; tastes. But it&#8217;ll take more than agility and tenacity to weather these lean times AND reach their goals. It&#8217;ll take reading the room much better than they have in the past. One would think, in a perfect world, that the healthcare industry would rally around a potential cure. That everyone would pull together to see if a disease that kills thousands each year can be stopped. But the world doesn&#8217;t work that way. For one thing, the disease is a multi-billion dollar industry. Another, less greedy, reason the technology will have to fight its way to the forefront is plain old healthy skepticism of the unproven, and there&#8217;s nothing wrong with that. It&#8217;s the company&#8217;s responsibility to prove the product has a place among the giants, and that&#8217;s exactly as it should be.<\/p>\n<p>Only time will tell whether this company is sliding slowly into oblivion or getting a good enough grip to climb out of the pit and into the sunshine.<\/p>\n<p>Lesson in investing in upstart medical device companies: $5000<br \/>\nLesson in writing and publishing fiction: Priceless<\/p>\n<p>\u00a9 M K Simonds<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Stock-in-trade: something that someone or something does or makes very well and often. So I bought this stock a few years ago. It seemed like a sure thing. The company was developing a technology that might revolutionize early treatment of &hellip; <a href=\"https:\/\/melissakaysimonds.com\/?p=621\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false}}},"categories":[16,15],"tags":[],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p8Mo02-a1","jetpack-related-posts":[{"id":295,"url":"https:\/\/melissakaysimonds.com\/?p=295","url_meta":{"origin":621,"position":0},"title":"Twisted","author":"lsimonds","date":"June 30, 2013","format":false,"excerpt":"\u201cThese things I have spoken to you, that in Me you may have peace. In the world you will have tribulation; but be of good cheer, I have overcome the world.\u201d John 16:33 \u201cDouble, double, toil and trouble; Fire burn, and cauldron bubble.\u201d The batch of trouble William Shakespeare\u2019s three\u2026","rel":"","context":"In &quot;2013&quot;","block_context":{"text":"2013","link":"https:\/\/melissakaysimonds.com\/?cat=10"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":424,"url":"https:\/\/melissakaysimonds.com\/?p=424","url_meta":{"origin":621,"position":1},"title":"On Wisemen And Wiseguys","author":"lsimonds","date":"November 30, 2014","format":false,"excerpt":"\u201cThen he said to me, \u201cWrite: Blessed are those who are called to the marriage supper of the Lamb!\u201d And he said to me, \u201cThese are the true sayings of God!\u201d And I fell at his feet to worship him. But he said to me, \u201cSee that you do not\u2026","rel":"","context":"In &quot;2014&quot;","block_context":{"text":"2014","link":"https:\/\/melissakaysimonds.com\/?cat=11"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":412,"url":"https:\/\/melissakaysimonds.com\/?p=412","url_meta":{"origin":621,"position":2},"title":"Time Is On Our Side, Yes It is","author":"lsimonds","date":"September 30, 2014","format":false,"excerpt":"\u201cThrough the LORD\u2019s mercies we are not consumed, because His compassions fail not. They are new every morning; great is Your faithfulness. \u2018The LORD is my portion,\u2019 says my soul, \u2018Therefore I hope in Him!\u2019\u201d Lamentations 3:22-24 This from Lynne Twist, founder of The Soul Of Money Institute, \u201cFor me,\u2026","rel":"","context":"In &quot;2014&quot;","block_context":{"text":"2014","link":"https:\/\/melissakaysimonds.com\/?cat=11"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":522,"url":"https:\/\/melissakaysimonds.com\/?p=522","url_meta":{"origin":621,"position":3},"title":"Not Enough","author":"lsimonds","date":"December 1, 2015","format":false,"excerpt":"\u201cSeven cows, plump and attractive, came up out of the Nile and fed in the reed grass. Seven other cows came up after them, poor and very ugly and thin, such as I had never seen in all the land of Egypt. And the thin, ugly cows ate up the\u2026","rel":"","context":"In &quot;2015&quot;","block_context":{"text":"2015","link":"https:\/\/melissakaysimonds.com\/?cat=13"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":1741,"url":"https:\/\/melissakaysimonds.com\/?p=1741","url_meta":{"origin":621,"position":4},"title":"Lost that Lovin\u2019 Feelin\u2019","author":"lsimonds","date":"January 31, 2023","format":false,"excerpt":"\u201cDear friends, let us continue to love one another, for love comes from God. Anyone who loves is a child of God and knows God.\u201d 1 John 4:7 This past Christmas Day, even though it was a lovely time spent with friends, I had\u2014as I always have\u2014a let-down feeling. I\u2019d\u2026","rel":"","context":"In &quot;2023&quot;","block_context":{"text":"2023","link":"https:\/\/melissakaysimonds.com\/?cat=24"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":268,"url":"https:\/\/melissakaysimonds.com\/?p=268","url_meta":{"origin":621,"position":5},"title":"Mission Impossible","author":"lsimonds","date":"February 28, 2013","format":false,"excerpt":"\u201cBut Jesus looked at them and said, \u2018With men it is impossible, but not with God; for with God all things are possible.\u201d Mark 10:27 I\u2019m really glad Brian De Palma and Company brought the wonderful spy thriller Mission Impossible to a new generation. I grew up glued to the\u2026","rel":"","context":"In &quot;2013&quot;","block_context":{"text":"2013","link":"https:\/\/melissakaysimonds.com\/?cat=10"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/melissakaysimonds.com\/index.php?rest_route=\/wp\/v2\/posts\/621"}],"collection":[{"href":"https:\/\/melissakaysimonds.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/melissakaysimonds.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/melissakaysimonds.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/melissakaysimonds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=621"}],"version-history":[{"count":21,"href":"https:\/\/melissakaysimonds.com\/index.php?rest_route=\/wp\/v2\/posts\/621\/revisions"}],"predecessor-version":[{"id":648,"href":"https:\/\/melissakaysimonds.com\/index.php?rest_route=\/wp\/v2\/posts\/621\/revisions\/648"}],"wp:attachment":[{"href":"https:\/\/melissakaysimonds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=621"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/melissakaysimonds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=621"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/melissakaysimonds.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=621"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}